Effectiveness of tacrolimus ointment on facial lesions refractory to topical corticosteroid in patients with atopic dermatitis receiving dupilumab

• Päätekijät: Hideaki Uchida (Tekijä), Masahiro Kamata (Tekijä), Shota Egawa (Tekijä), Mayumi Nagata (Tekijä), Saki Fukaya (Tekijä), Kotaro Hayashi (Tekijä), Atsuko Fukuyasu (Tekijä), Takamitsu Tanaka (Tekijä), Takeko Ishikawa (Tekijä), Takamitsu Ohnishi (Tekijä), Yayoi Tada (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Frontiers Media S.A., 2022-02-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Abstract Dupilumab demonstrated high efficacy and tolerable safety profiles in moderate‐to‐severe atopic dermatitis (AD) patients in clinical trials; however, certain patients suffer from facial redness, while obtaining good responses on the trunk and limbs to dupilumab in the real‐world setting. In...